0001209191-22-016872.txt : 20220307
0001209191-22-016872.hdr.sgml : 20220307
20220307195801
ACCESSION NUMBER: 0001209191-22-016872
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220304
FILED AS OF DATE: 20220307
DATE AS OF CHANGE: 20220307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kanner Steven
CENTRAL INDEX KEY: 0001871131
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40631
FILM NUMBER: 22719988
MAIL ADDRESS:
STREET 1: CARIBOU BIOSCIENCES, INC.
STREET 2: 2929 7TH STREET, SUITE 105
CITY: BERKELEY
STATE: CA
ZIP: 94710
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Caribou Biosciences, Inc.
CENTRAL INDEX KEY: 0001619856
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 453728228
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 7TH STREET, SUITE 105
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 510-982-6030
MAIL ADDRESS:
STREET 1: 2929 7TH STREET, SUITE 105
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-04
0
0001619856
Caribou Biosciences, Inc.
CRBU
0001871131
Kanner Steven
C/O CARIBOU BIOSCIENCES, INC.
2929 7TH STREET, SUITE 105
BERKELEY
CA
94710
0
1
0
0
Chief Scientific Officer
Common Stock
2022-03-04
4
M
0
9171
2.69
A
226090
D
Common Stock
2022-03-04
4
M
0
1549
4.11
A
227639
D
Option to purchase Common Stock
2.69
2022-03-04
4
M
0
9171
0.00
D
2029-09-30
Common Stock
9171
122963
D
Option to purchase Common Stock
4.11
2022-03-04
4
M
0
1549
0.00
D
2031-03-29
Common Stock
1549
230365
D
Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021.
Includes 1,888 shares purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan on February 15, 2022 for $9.85 per share.
1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
1/4th of the shares subject to this option vested on March 2, 2022 and an additional 1/48th of the aggregate number of shares subject to the option will vest on the corresponding day of each month thereafter until the option is fully vested, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
/s/ Barbara G. McClung, at attorney-in-fact
2022-03-07